- Home
- GGR vs CRVO Comparison
GGR vs CRVO Comparison
Compare GGR & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GGR | CRVO |
|---|---|---|
| Founded | 2011 | 2001 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.7M | 47.7M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | GGR | CRVO |
|---|---|---|
| Price | $3.43 | $3.62 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | 16.2K | ★ 80.2K |
| Earning Date | 05-07-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,006,510.00 |
| Revenue This Year | $5.07 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.19 | $3.58 |
| 52 Week High | $6.21 | $14.00 |
Technical Indicators
Market Signals| Indicator | GGR | CRVO |
|---|---|---|
| Relative Strength Index (RSI) | 49.06 | 33.96 |
| Support Level | $3.20 | $3.58 |
| Resistance Level | $3.55 | $5.24 |
| Average True Range (ATR) | 0.17 | 0.37 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 20.29 | 6.76 |
Price Performance
Historical ComparisonAbout GGR Gogoro Inc.
Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.